Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.

Merkel O, Kenner L, Turner SD. Leukemia. Dec,25(12):1795-6. doi: 10.1038/leu.2011.295.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

Poeppl, W, Hell, M, Herkner, H, Stoiser, B, Fritsche, G, Schurz-Bamieh, N, Poeppl, G, Gattringer, R, Jones, N, Maass, M, Egle, A, Burgmann, H, Infection. 2011 Aug,39(4):341-52. doi: 10.1007/s15010-011-0121-9. Epub 2011 May 5.

R-CHOP plus thalidomide for previously untreated patients with mantle cell lymphoma (AGMT NHL-11 trial)

Drach, J, Hopfinger, G, Fridrik, M, Greil, R, Thaler, J, Willenbacher, W, Lang, A, Jager, U, Raderer, M ONKOLOGIE. 2011, 34: 75-75.

DOSE-ESCALATION WITH BEACOPP ESCALATED IS SUPERIOR TO ABVD IN THE COMBINED-MODALITY TREATMENT OF EARLY UNFAVORABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD14 TRIAL

Borchmann, P, Diehl, V, Plutschow, A, Von Tresckow, B, Markova, J, Hitz, F, Kra, Z, Greil, R, Topp, MS, Villalobos, M, Zijlstra, JM, Sokler, M, Fuchs, M, Engert, A ANN ONCOL. 2011, 22: 180-180.

Lower incidence of BCR-ABL mutations and improved molecular response kinetics in newly diagnosed CML patients treated with nilotinib compared with imatinib

Muller, MC, le Coutre, P, Gattermann, N, Scheid, C, Al-Ali, HK, Ottmann, OG, Duyster, J, Blumenstengel, K, Brummendorf, TH, Greil, R, Chalandon, Y, Valent, P, Stegelmann, F, Kneba, M, Schafhausen, P, Saussele, S, Frank, O, Larson, RA, Saglio, G, Hochhaus, A, Lange, T ONKOLOGIE. 2011, 34: 266-266.

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Poestlberger, S, Steger, G, Jakesz, R, Singer, C, Eidtmann, H, Greil, R BONE. 2011, 48(1): S17-S17.

The oncogenic miR-17-92 cluster and miR-155 define ALK status in anaplastic large cell lymphoma

Griessl, R, Hamacher, F, Sifft, E, Scheideler, M, Kenner, L, Greil, R, Merkel, O ONKOLOGIE. 2011, 34: 135-135.

Parp Inhibitoren

Ressler Sigrun, Mlineritsch Brigitte, Greil Richard Universum Innere Medizin. 2011.

Bisphosphonate in der Therapie des Mammakarzinoms

Ressler Sigrun, Mlineritsch Brigitte, Greil Richard MEDIUM. 2011. 3: 26-30.

Bedeutung des RANK / RANK-Ligand Systems beim Mammakarzinom: Biologische Grundlagen.

Ressler Sigrun, Mlineritsch Brigitte, Greil Richard Universum Innere Medizin. 2011.